Cancer risk confirmed in primary sclerosing cholangitis

The first Australian study of primary sclerosing cholangitis (PSC) has confirmed a high rate of gastrointestinal malignancy especially in patients who also have inflammatory bowel disease (IBD). The retrospective study of 208 patients from two tertiary referral hospitals in Sydney found 22% of patients with both PSC and IBD developed cancers including cholangiocarcinoma, colorectal adenocarcinoma ...

Already a member?

Login to keep reading.

© 2022 the limbic